| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1292590B1 Admantane derivatives |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | EP1200320B9 Valve with a two-component seal |
| 01/18/2006 | CN1723480A System and method for transparent early detection, warning, and intervention during a medical procedure |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1720995A The treatment of respiratory diseases |
| 01/18/2006 | CN1720980A Drug-dropping soft capsule and its preparing process |
| 01/18/2006 | CN1720975A Asari dripping pills and its preparation process |
| 01/18/2006 | CN1720969A Chinese proprietary medicine |
| 01/18/2006 | CN1720936A Medicine for treating breadth gasp, cough, asthma and phelgm |
| 01/18/2006 | CN1720918A Compound capsule with dextromethorphan and promethazine and method for preparing the same |
| 01/18/2006 | CN1720917A Cough treating orally disintegrating tablet |
| 01/18/2006 | CN1720911A Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof |
| 01/18/2006 | CN1720906A Asthma treating spray |
| 01/18/2006 | CN1720905A Application of beta-Asarone in pharmacy |
| 01/18/2006 | CN1237184C Target for medicine against SARS-Cov and medicine screening method and medicine against SARS |
| 01/18/2006 | CN1237076C Polypeptide variants with altered effector function |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236788C Medicine for curing upper respiratory tract infection and preparation method of its granule preparation |
| 01/18/2006 | CN1236784C Wolf oil pill for treating cough and asthma |
| 01/18/2006 | CN1236783C Herb kalimeris indica infusion preparation method |
| 01/18/2006 | CN1236774C Highly concentrated stable meloxicam solutions |
| 01/18/2006 | CN1236769C Inhibitor for inhibiting cell adhesion |
| 01/18/2006 | CN1236765C Levoimidazole for treating nasal polyp and nasal polyposis |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987093 Single dose azithromycin |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6986889 Complexing; removal from blood circulation |
| 01/17/2006 | US6986346 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |
| 01/12/2006 | WO2006002453A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 01/12/2006 | WO2005113483A3 Levalbuterol hydrochloride polymorph a |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009437 A medicament containing formoterol or formoterol fumarate and/or mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease; inhalable form in an atomizable composition or in a dry powder |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060008542 Preparation containing a mixture of picrorrhiza and ginkgo for the relief of disease |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572310A1 Sphingolipid-derived pharmaceutical compositions |
| 01/12/2006 | CA2571588A1 Pyrazolopyridine derivatives |
| 01/12/2006 | CA2571519A1 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/12/2006 | CA2569727A1 Compounds |
| 01/12/2006 | CA2569716A1 Hydantoin derivatives for the treatment of obstructive airway diseases |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/12/2006 | CA2568834A1 Medicaments for inhalation comprising steroids and an anticholinergic |
| 01/11/2006 | EP1614681A1 Fexofenadine polymorphs and process for the preparation thereof |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1614420A2 Treatment of hypertension, angina and other disorders using (-) amlodipine |
| 01/11/2006 | EP1613315A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/11/2006 | EP1613310A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 01/11/2006 | EP1613282A1 Formulations and methods for treating rhinosinusitis |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1442036B1 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN2750811Y Stype for radical treatment of nasal polyp |
| 01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
| 01/11/2006 | CN1720058A Development of an anti-cough, anti-tussive and throat soothing herbal formulation |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720036A Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 01/11/2006 | CN1720032A Method for preventing and/or treating asthma by PBPB |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718585A Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 01/11/2006 | CN1718240A Use of recombinant human interferon omega for treating anaphylactic rhinitis |
| 01/11/2006 | CN1718222A Anti-inflammation buccal tablet |
| 01/11/2006 | CN1718181A Medicine of (4-alkynyl)-aromatic keto-acid compounds for treating chronic obstructive lung diseases |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235890C Thizaolyl amide derivatives |
| 01/11/2006 | CN1235610C Chinese medicinal composition for treating acute pharyngitis and gingivitis and preparing method thereof |
| 01/11/2006 | CN1235600C Phenergan bile tablet and preparing process thereof |
| 01/11/2006 | CN1235598C Process for preparing buccal lozenge contg. compound sede-iodine |
| 01/11/2006 | CN1235596C Spray for treating asthma and its preparing method |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/11/2006 | CN1235568C Aqueous-based pharmaceutical composition |
| 01/11/2006 | CN1235524C Method for making cigarette for nasal health |